Clinical Study
New Rising Infection: Human Herpesvirus 6 Is Frequent in Myeloma Patients Undergoing Autologous Stem Cell Transplantation after Induction Therapy with Bortezomib
Table 3
Risk factors for HHV6 reactivation after autologous SCT*.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Calculation represents the proportion of HHV-6 infection in screened patients that were treated with the same induction regimen (VD or TD, resp.). |